PharmD, University of Toronto, Toronto, Ontario, Canada

Nabil has been a health care Consultant with McKesson for over 25 years, specializing in market access strategies, reimbursement submissions, medical writing, and real-world evidence (RWE) projects and studies. He has an undergraduate degree in Pharmacy from Massachusetts College of Pharmacy and a Doctor of Pharmacy degree from the University of Toronto. Nabil has also worked as a pharmacist in both Canada and the U.S. His clinical education, practical experience as a health care provider, and broad expertise as a Consultant with McKesson for almost three decades has given him a unique and keen understanding of the complex therapeutic, market access, and health care issues faced by patients, providers, manufacturers, and payers.

Nabil has extensive experience in implementing RWE studies and managed McKesson’s first RWE study over 20 years ago. Since then, he has helped design and manage numerous RWE studies using both retrospective and prospective methodologies. He has worked with McKesson’s Patient Support Programs, INVIVA infusion clinics, and Provider Solutions teams to integrate real-world data (RWD) into these important services. And Nabil has also worked with McKesson’s significant oncology businesses in the US (US Oncology and Ontada) on RWE studies utilizing their huge EMR database of real-world oncology data. Throughout his career, Nabil has helped many, significant products gain access to the Canadian market, having worked in over 40 therapeutic areas, including oncology, immunology, hepatology, ophthalmology, and rare diseases. In doing so, Nabil has developed solutions to complex market access problems, successfully completed numerous payer submissions, and provided our customers with important data insights.